In addition, miR-22 inhibits estrogen signaling by directly targeting estrogen receptor alpha [38], and its overexpression suppresses growth and induces senescence-like phenotypes in human breast epithelial and cancer cells [39]. This evidence concerns the gene ESR1 and cancer.